218 related articles for article (PubMed ID: 11920609)
1. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer.
Murayama Y; Miyagawa J; Shinomura Y; Kanayama S; Isozaki K; Yamamori K; Mizuno H; Ishiguro S; Kiyohara T; Miyazaki Y; Taniguchi N; Higashiyama S; Matsuzawa Y
Int J Cancer; 2002 Apr; 98(4):505-13. PubMed ID: 11920609
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability.
Takemura T; Hino S; Murata Y; Yanagida H; Okada M; Yoshioka K; Harris RC
Kidney Int; 1999 Jan; 55(1):71-81. PubMed ID: 9893115
[TBL] [Abstract][Full Text] [Related]
3. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.
Higashiyama S; Iwamoto R; Goishi K; Raab G; Taniguchi N; Klagsbrun M; Mekada E
J Cell Biol; 1995 Mar; 128(5):929-38. PubMed ID: 7876316
[TBL] [Abstract][Full Text] [Related]
4. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation.
Nishida M; Miyagawa J; Yamashita S; Higashiyama S; Nakata A; Ouchi N; Tamura R; Yamamori K; Kihara S; Taniguchi N; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1236-43. PubMed ID: 10807738
[TBL] [Abstract][Full Text] [Related]
5. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity.
Nakamura K; Mitamura T; Takahashi T; Kobayashi T; Mekada E
J Biol Chem; 2000 Jun; 275(24):18284-90. PubMed ID: 10749879
[TBL] [Abstract][Full Text] [Related]
6. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.
Nakamura K; Iwamoto R; Mekada E
J Cell Biol; 1995 Jun; 129(6):1691-705. PubMed ID: 7790364
[TBL] [Abstract][Full Text] [Related]
7. Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages.
Ouchi N; Kihara S; Yamashita S; Higashiyama S; Nakagawa T; Shimomura I; Funahashi T; Kameda-Takemura K; Kawata S; Taniguchi N; Matsuzawa Y
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):923-8. PubMed ID: 9396739
[TBL] [Abstract][Full Text] [Related]
8. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.
Inui S; Higashiyama S; Hashimoto K; Higashiyama M; Yoshikawa K; Taniguchi N
J Cell Physiol; 1997 Jun; 171(3):291-8. PubMed ID: 9180898
[TBL] [Abstract][Full Text] [Related]
9. CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain.
Sakuma T; Higashiyama S; Hosoe S; Hayashi S; Taniguchi N
J Biochem; 1997 Aug; 122(2):474-80. PubMed ID: 9378729
[TBL] [Abstract][Full Text] [Related]
10. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor.
Shishido Y; Sharma KD; Higashiyama S; Klagsbrun M; Mekada E
J Biol Chem; 1995 Dec; 270(49):29578-85. PubMed ID: 7494001
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical distribution of CD9, heparin binding epidermal growth factor-like growth factor, and integrin alpha3beta1 in normal human tissues.
Nakamura Y; Handa K; Iwamoto R; Tsukamoto T; Takahasi M; Mekada E
J Histochem Cytochem; 2001 Apr; 49(4):439-44. PubMed ID: 11259446
[TBL] [Abstract][Full Text] [Related]
12. Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor.
Takemura T; Hino S; Kuwajima H; Yanagida H; Okada M; Nagata M; Sasaki S; Barasch J; Harris RC; Yoshioka K
J Am Soc Nephrol; 2001 May; 12(5):964-972. PubMed ID: 11316855
[TBL] [Abstract][Full Text] [Related]
13. Cell surface monkey CD9 antigen is a coreceptor that increases diphtheria toxin sensitivity and diphtheria toxin receptor affinity.
Cha JH; Brooke JS; Ivey KN; Eidels L
J Biol Chem; 2000 Mar; 275(10):6901-7. PubMed ID: 10702250
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
Goishi K; Higashiyama S; Klagsbrun M; Nakano N; Umata T; Ishikawa M; Mekada E; Taniguchi N
Mol Biol Cell; 1995 Aug; 6(8):967-80. PubMed ID: 7579712
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas.
Mishima K; Higashiyama S; Asai A; Yamaoka K; Nagashima Y; Taniguchi N; Kitanaka C; Kirino T; Kuchino Y
Acta Neuropathol; 1998 Oct; 96(4):322-8. PubMed ID: 9796995
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal processing of cell surface heparin-binding epidermal growth factor-like growth factor up-regulates its juxtacrine but not its paracrine growth factor activity.
Nakagawa T; Higashiyama S; Mitamura T; Mekada E; Taniguchi N
J Biol Chem; 1996 Nov; 271(48):30858-63. PubMed ID: 8940069
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding EGF-like growth factor: a juxtacrine growth factor.
Iwamoto R; Mekada E
Cytokine Growth Factor Rev; 2000 Dec; 11(4):335-44. PubMed ID: 10959080
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
[TBL] [Abstract][Full Text] [Related]
19. Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa.
Murayama Y; Miyagawa J; Higashiyama S; Kondo S; Yabu M; Isozaki K; Kayanoki Y; Kanayama S; Shinomura Y; Taniguchi N
Gastroenterology; 1995 Oct; 109(4):1051-9. PubMed ID: 7557069
[TBL] [Abstract][Full Text] [Related]
20. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma.
Inui Y; Higashiyama S; Kawata S; Tamura S; Miyagawa J; Taniguchi N; Matsuzawa Y
Gastroenterology; 1994 Dec; 107(6):1799-804. PubMed ID: 7958694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
